Circulating DNA in the blood of gastric cancer patients

Ann N Y Acad Sci. 2008 Aug:1137:226-31. doi: 10.1196/annals.1448.009.

Abstract

The concentration of cell-free DNA and promoter methylation status of the MGMT, p15, and hMLH1 genes were analyzed by a fluorescence-based assay and methylation-specific PCR (MSP) in the blood of gastric cancer patients (n= 20) and healthy subjects (n= 22). Gastric cancer patients were characterized by an increased concentration of circulating DNA in the plasma; the amount of cell-surface-bound DNA was not decreased compared with controls and amounted to 80 +/- 15% of the total circulating DNA. MSP analysis of three genes in the cell-surface-bound DNA permits the detection of gastric cancer patients with a sensitivity of 75% and a specificity of 54%. Thus, the cell-surface-bound DNA is a convenient source of DNA for MSP analysis of cancer-specific markers. The data on the presence of methylated DNA in plasma combined with the analysis of other cancer-related changes in DNA can significantly contribute to cancer diagnostics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics
  • Carrier Proteins / genetics
  • DNA / blood*
  • DNA / genetics*
  • DNA Methylation
  • DNA Modification Methylases / genetics
  • DNA Repair Enzymes / genetics
  • DNA-Binding Proteins
  • Female
  • Humans
  • Male
  • Middle Aged
  • MutL Protein Homolog 1
  • Nuclear Proteins / genetics
  • Promoter Regions, Genetic
  • Stomach Neoplasms / blood*
  • Stomach Neoplasms / diagnosis
  • Stomach Neoplasms / genetics*
  • Tumor Suppressor Proteins / genetics

Substances

  • Adaptor Proteins, Signal Transducing
  • Carrier Proteins
  • DNA-Binding Proteins
  • MLH1 protein, human
  • Nuclear Proteins
  • PCLAF protein, human
  • Tumor Suppressor Proteins
  • DNA
  • DNA Modification Methylases
  • MGMT protein, human
  • MutL Protein Homolog 1
  • DNA Repair Enzymes